Hysterectomy (Surgical Resection)

Treatment for Uterine Cancer

Typical Dosage: Surgical procedure

Effectiveness
90%
Safety Score
45%
Clinical Trials
41
Participants
1M

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
45
DangerousModerateSafe
Treatment Details
Dosage Range
Surgical procedure
Time to Effect
Immediate
Treatment Duration
One-time procedure, 4-8 weeks recovery
Evidence Quality
HIGH
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$500
Monitoring:$10,000
Side Effect Mgmt:$1,500
Total Annual:$25,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
3.5
Outcome-Based Costs
Cost per Remission
$29,412
Hysterectomy (Surgical Resection) Outcomes

for Uterine Cancer

Efficacy Outcomes
Overall Effectiveness
+90%
Remission Rate
+85%
Common Side Effects
Pain
+90%
Infection
+10%
Bleeding
+5%
Damage to adjacent organs
+2%
Deep vein thrombosis/Pulmonary embolism
+1%
Lymphedema (with lymphadenectomy)
+20%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
4 active trials recruiting for Hysterectomy (Surgical Resection) in Uterine Cancer

Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma

NCT06191133RECRUITINGPHASE1
View Study
24 participants
INTERVENTIONAL
Cleveland, United States
Started: Nov 20, 2024

Modified Tumor-free Techniques Operation to Cervical Cancer

NCT06836869RECRUITINGNA
View Study
524 participants
INTERVENTIONAL
Lanzhou, China +12 more
Started: Feb 20, 2025

Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IA1 With LVSI, IA2)

NCT04934982RECRUITINGNA
View Study
690 participants
INTERVENTIONAL
Shanghai, China
Started: Sep 24, 2021

Robot-assisted Approach to Cervical Cancer

NCT03719547RECRUITINGNA
View Study
800 participants
INTERVENTIONAL
Stockholm, Sweden
Started: May 28, 2019
Completed Clinical Trials
5 completed trials for Hysterectomy (Surgical Resection) in Uterine Cancer

CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer

NCT00610740COMPLETEDPHASE2
View Study
18 participants
INTERVENTIONAL
Minneapolis, United States
Started: Jul 1, 2006

Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus

NCT00002706COMPLETEDPHASE3
View Study
2.62K participants
INTERVENTIONAL
Philadelphia, United States
Started: Apr 1, 1996

Complete Nerve-Sparing Radical Hysterectomy for Cervical Cancer

NCT02562729COMPLETEDPHASE2
View Study
62 participants
INTERVENTIONAL
Shanghai, China
Started: Sep 1, 2015

Randomized Controlled Trial (RCT)Comparing GYNAECARE MORCELLEX Versus ROTOCUT GI Tissue Morcellators

NCT00743080COMPLETEDPHASE4
View Study
INTERVENTIONAL
Catanzaro, Italy
Started: Jan 1, 2008

Laparoscopic Approach to Cancer of the Endometrium

NCT00096408COMPLETEDPHASE3
View Study
760 participants
INTERVENTIONAL
Camperdown, Australia +22 more
Started: Oct 1, 2005
Showing 20 of 41 total trials